Displaying 1 - 1 of 1
| Active Ingredient | SERTRALINE |
| Therapeutic Class | SELECTIVE SEROTONIN REUPTAKE INHIBITORS |
| Indications |
Major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder and social phobia. |
| Caution | Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies with major depressive disorder (MDD) and other psychiatric disorde More ... |
| Dose Range |
Adult: 50 mg daily increased, if necessary, in increments of 50 mg at intervals of at least a week to a maximum of 200 mg daily. Child: Obsessive-compulsive disorder: children 6-12 yr, 25mg/day, 13-17 yr, 50mg/day orally as a single dose in the morning or |
| Drug Interactions | |
| Pregnancy | Category C |
| Breast Feeding |